Strategies for More Effective Monitoring and Evaluation Systems in HIV Programmatic Scale-Up in Resource-Limited Settings: Implications for Health Systems Strengthening

2009 ◽  
Vol 52 ◽  
pp. S58-S62 ◽  
Author(s):  
Denis Nash ◽  
Batya Elul ◽  
Miriam Rabkin ◽  
May Tun ◽  
Suzue Saito ◽  
...  
Keyword(s):  
Health Systems ◽  
Scale Up ◽  
Monitoring And Evaluation ◽  
Health Systems Strengthening ◽  
Resource Limited Settings ◽  
Evaluation Systems ◽  
Resource Limited

Developing Laboratory Systems and Infrastructure for HIV Scale-Up: A Tool for Health Systems Strengthening in Resource-Limited Settings

2009 ◽  
Vol 52 ◽  
pp. S30-S33 ◽  
Author(s):  
Jessica E Justman ◽  
Stephania Koblavi-Deme ◽  
Amilcar Tanuri ◽  
Allison Goldberg ◽  
Luis Felipe Gonzalez ◽  
...  
Keyword(s):  
Health Systems ◽  
Scale Up ◽  
Health Systems Strengthening ◽  
Resource Limited Settings ◽  
Resource Limited

scholarly journals Challenges faced by cancer patients in Uganda: Implications for health systems strengthening in resource limited settings

2021 ◽  
Vol 27 ◽  
pp. 100263
Author(s):  
Annet Nakaganda ◽  
Kristen Solt ◽  
Leocadia Kwagonza ◽  
Deborah Driscoll ◽  
Rebecca Kampi ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Health Systems ◽  
Health Systems Strengthening ◽  
Resource Limited Settings ◽  
Resource Limited

Informatics for Medicines Management Systems in Resource-Limited Settings

2012 ◽  
pp. 634-645
Author(s):  
Andy Stergachis ◽  
Douglas Keene ◽  
Shabir Somani
Keyword(s):  
Information Technologies ◽  
Care Delivery ◽  
Monitoring And Evaluation ◽  
Management Systems ◽  
Medicines Management ◽  
Resource Limited Settings ◽  
Treatment And Prevention ◽  
Resource Limited ◽  
Key Stakeholders ◽  
Potential Benefits

Improved access to information is necessary to ensure achievement of the potential benefits of medicines in resource-limited countries. The scaling up of treatment and prevention programs involving medicines in resource-limited regions with high disease burdens requires proper and urgent attention to the development and use of information technologies. Areas of need for medicines management systems informatics include prescribing, dispensing, pharmaceutical care, administration, patient monitoring, education and training, supply chain management, and monitoring and evaluation of program performance. Such information systems should strive to collect and manage data that are a standardized, compiled, and made easily accessible for use by key stakeholders, including ministries of health, medicines regulators, pharmaceutical industry, public health programs, academic researchers, donor organizations, the health care delivery sector, and ultimately the public and patients. A framework is described for medicines management systems informatics in resource-limited settings.

scholarly journals Using a mentorship model to localise the Practical Approach to Care Kit (PACK): from South Africa to Ethiopia

2018 ◽  
Vol 3 (Suppl 5) ◽  
pp. e001108 ◽  
Author(s):  
Yibeltal Mekonnen ◽  
Charlotte Hanlon ◽  
Solomon Emyu ◽  
Ruth Vania Cornick ◽  
Lara Fairall ◽  
...  
Keyword(s):  
Primary Care ◽  
Health Systems ◽  
Addis Ababa ◽  
Scale Up ◽  
Health Systems Strengthening ◽  
Sub Saharan Africa ◽  
Practical Approach ◽  
Supervisory Support ◽  
Ministry Of Health ◽  
Systems Research

The Federal Ministry of Health, Ethiopia, recognised the potential of the Practical Approach to Care Kit (PACK) programme to promote integrated, comprehensive and evidence-informed primary care as a means to achieving universal health coverage. Localisation of the PACK guide to become the ‘Ethiopian Primary Health Care Clinical Guidelines’ (PHCG) was spearheaded by a core team of Ethiopian policy and technical experts, mentored by the Knowledge Translation Unit, University of Cape Town. A research collaboration, ASSET (heAlth Systems StrEngThening in sub-Saharan Africa), has brought together policy-makers from the Ministry of Health and health systems researchers from Ethiopia (Addis Ababa University) and overseas partners for the PACK localisation process, and will develop, implement and evaluate health systems strengthening interventions needed for a successful scale-up of the Ethiopian PHCG. Localisation of PACK for Ethiopia included expanding the guide to include a wider range of infectious diseases and an expanded age range (from 5 to 15 years). Early feedback from front-line primary healthcare (PHC) workers is positive: the guide gives them greater confidence and is easy to understand and use. A training cascade has been initiated, with a view to implementing in 400 PHC facilities in phase 1, followed by scale-up to all 3724 health centres in Ethiopia during 2019. Monitoring and evaluation of the Ministry of Health implementation at scale will be complemented by indepth evaluation by ASSET in demonstration districts. Anticipated challenges include availability of essential medications and laboratory investigations and the need for additional training and supervisory support to deliver care for non-communicable diseases and mental health. The strong leadership from the Ministry of Health of Ethiopia combined with a productive collaboration with health systems research partners can help to ensure that Ethiopian PHCG achieves standardisation of clinical practice at the primary care level and quality healthcare for all.

scholarly journals EDITORIAL: COVID-19: Rebooting pharmacy education in resource-limited settings

2021 ◽  
pp. 67-70
Author(s):  
Jennie Lates ◽  
Dan Kibuule
Keyword(s):  
Health Systems ◽  
World Health Organisation ◽  
Pharmacy Education ◽  
Sub Saharan Africa ◽  
World Health ◽  
Resource Limited Settings ◽  
Non Communicable Diseases ◽  
High Burden ◽  
Resource Limited ◽  
Sub Saharan

Globally, the COVID-19 pandemic has aggravated inequalities in access to quality pharmacy education, particularly in resource-limited settings in Africa (Engle, 2020; Fuller et al., 2020). This is a serious concern for Africa especially, given that sub-Saharan Africa ranks lowest on the global pharmaceutical workforce index and has a disproportionately high burden of infectious and non-communicable diseases, combined with weak health systems (World Health Organisation [WHO], 2013; Bates et al., 2018).

scholarly journals Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program

2012 ◽  
Vol 6 (11) ◽  
pp. 806-808
Author(s):  
Tinashe Mudzviti ◽  
Marvelous Sibanda ◽  
Samuel Gavi ◽  
Charles Chiedza Maponga ◽  
Gene D Morse
Keyword(s):  
Antiretroviral Therapy ◽  
Adverse Drug Reactions ◽  
Highly Active Antiretroviral Therapy ◽  
Family Care ◽  
Monitoring And Evaluation ◽  
Drug Reactions ◽  
Resource Limited Settings ◽  
Drug Regulatory Authority ◽  
Highly Active ◽  
Resource Limited

Introduction: Cutaneous adverse drug reactions (cADRs) can cause significant morbidity and distress in patients, especially in the HIV-infected population on antiretroviral therapy. Adverse drug reaction monitoring and ascertaining causality in resource-limited settings remain serious challenges. This study was conducted to evaluate causality and measure the incidence of cADRs in HIV-infected patients on highly active antiretroviral therapy. The study was also designed to test a three-step approach in the monitoring and evaluation of ADRs in resource-limited settings. Methodology: A retrospective review of patient medical records was performed at the Parirenyatwa Family Care Centre, Harare, Zimbabwe. Cases of cADRs were reported to the Medicines Control Authority of Zimbabwe, the main drug regulating body in Zimbabwe, for assessment and causality classification. Results: We reviewed 221 randomly selected patient records to determine whether any diagnoses of cADRs were made by clinicians. Causality assessment revealed that 13.1% of cADRs were due to an offending agent in the antiretroviral therapy versus an initial incidence of 17.6% which had been determined by the physicians. Conclusions: cADRs had an incidence of 13.1% within the population under study due to non nucleoside reverse transcriptase inhibitors (NNRTIs). Most reactions were caused by the NNRTIs which contributed 72.4 % of all cADRs. A panel of experts from the drug regulatory authority can be used as an implementation based mechanism in ascertaining causality objectively in settings where resources are constrained.

Sign in / Sign up

Export Citation Format

Share Document